To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresFig. 1Panel A: Kaplan–Meier estimated mortality. At 24 months, mortality was 17.2% in failed CS implants and 22.8% in prior non-responders, with a HR of 1.54 estimated from Cox regression (95% confidence interval [CI] 0.65–3.65; p = .32).Panel B: Average LVESVi at different visits. Error bars represent 1 standard deviation.Panel C: LVEF at different visits.